Trials / Completed
CompletedNCT01877876
Assessing the Accuracy of the RevK Sensor
Assessing the Accuracy of the RevK Sensor for Non-Invasive Hemoglobin Monitoring
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Evaluation of a new generation of sensors for monitoring blood hemoglobin. The newest version is RevK.
Detailed description
Evaluation of a new generation of sensors for monitoring blood hemoglobin with the Masimo non-invasive hemoglobin monitor. The newest sensor version is RevK.
Conditions
Timeline
- Start date
- 2013-06-01
- Primary completion
- 2014-12-01
- Completion
- 2015-06-01
- First posted
- 2013-06-14
- Last updated
- 2015-06-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01877876. Inclusion in this directory is not an endorsement.